Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR

BACKGROUND: Inhibitors targeting immune checkpoint were proved effective in cancer immunotherapy, such as PD-1/PD-L1 blockade. The novel immune checkpoint TIGIT/PVR plays critical roles in suppressing the anti-tumor effects of CD8(+) T and NK cells, and dual blockade of TIGIT/PVR and PD-1/PD-L1 by a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cell Commun Signal
Main Authors: Zhou, Xiuman, Du, Jiangfeng, Wang, Hongfei, Chen, Chunxia, Jiao, Ling, Cheng, Xiangrui, Zhou, Xiaowen, Chen, Shaomeng, Gou, Shanshan, Zhao, Wenshan, Zhai, Wenjie, Chen, Junhui, Gao, Yanfeng
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487564/
https://ncbi.nlm.nih.gov/pubmed/32894141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-020-00638-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍